Compare Ascendis Pharma A/S (ASND) vs Toronto-Dominion Bank (TD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ascendis Pharma A/S vs Toronto-Dominion Bank — how do they compare? Ascendis Pharma A/S trades at $254 (market cap $16.67B), while Toronto-Dominion Bank trades at $121.35 (market cap $200.48B). The key difference: Toronto-Dominion Bank is far larger — about 12× Ascendis Pharma A/S's market cap, and Toronto-Dominion Bank pays a 2.63% dividend while Ascendis Pharma A/S pays none. Which is the better fit depends on your goals.
| ASND | TD | |
|---|---|---|
Market Cap | $16.67B | $200.48B |
Sector | Health | Financials |
52-Week High | $277.18 | $124.80 |
52-Week Low | $189.74 | $72.85 |
Enterprise Value | $17.04B | — |
Dividend Yield | — | 2.63% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →About Toronto-Dominion Bank
Toronto-Dominion is one of Canada's two largest banks and operates three business segments: Canadian retail banking, U.S. retail banking, and wholesale banking. The bank's U.S. operations span from Maine to Florida, with a strong presence in the Northeast. It also has a 13% ownership stake in Charles Schwab.
Read more on TD →
